Simplex Trading, LLC Compugen LTD Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$1.68 - $2.52 $28,717 - $43,076	-17,094 Reduced 96.59%	603 $1,000
Q1 2024 Apr 25, 2024	BUY	$1.75 - $2.95 $10,990 - $18,526	6,280 Added 55.01%	17,697 $45,000
Q4 2023 Feb 02, 2024	BUY	$0.53 - $2.0 $6,051 - $22,834	11,417 New	11,417 $22,000
Q2 2023 Aug 04, 2023	SELL	$0.57 - $1.38 $7,325 - $17,735	-12,852 Reduced 99.13%	113 $0
Q1 2023 Apr 27, 2023	SELL	$0.68 - $1.11 $1,022 - $1,668	-1,503 Reduced 10.39%	12,965 $9,000
Q4 2022 Feb 02, 2023	SELL	$0.58 - $1.2 $7,754 - $16,042	-13,369 Reduced 48.03%	14,468 $10,000
Q3 2022 Nov 04, 2022	SELL	$0.66 - $2.32 $837 - $2,944	-1,269 Reduced 4.36%	27,837 $18,000
Q2 2022 Aug 03, 2022	BUY	$1.57 - $3.33 $45,696 - $96,922	29,106 New	29,106 $53,000
Q1 2022 May 02, 2022	SELL	$2.76 - $4.64 $2,315 - $3,892	-839 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$4.09 - $7.16 $97,550 - $170,773	-23,851 Reduced 96.6%	839 $3,000
Q3 2021 Oct 28, 2021	SELL	$5.8 - $8.02 $27,126 - $37,509	-4,677 Reduced 15.93%	24,690 $197,000
Q2 2021 Aug 12, 2021	BUY	$6.87 - $9.16 $79,588 - $106,118	11,585 Added 65.15%	29,367 $243,000
Q1 2021 Apr 26, 2021	BUY	$7.67 - $13.77 $135,812 - $243,825	17,707 Added 23609.33%	17,782 $152,000
Q3 2020 Oct 14, 2020	SELL	$14.16 - $19.45 $15,236 - $20,928	-1,076 Reduced 93.48%	75 $1,000
Q2 2020 Jul 13, 2020	SELL	$6.97 - $17.12 $65,657 - $161,270	-9,420 Reduced 89.11%	1,151 $17,000
Q1 2020 Apr 29, 2020	BUY	$5.79 - $11.83 $10,670 - $21,802	1,843 Added 21.12%	10,571 $76,000
Q4 2019 Feb 05, 2020	SELL	$3.9 - $6.16 $79,189 - $125,078	-20,305 Reduced 69.94%	8,728 $52,000
Q3 2019 Oct 15, 2019	SELL	$3.01 - $4.49 $56,338 - $84,039	-18,717 Reduced 39.2%	29,033 $122,000
Q2 2019 Jul 26, 2019	BUY	$2.8 - $4.14 $88,547 - $130,923	31,624 Added 196.11%	47,750 $183,000
Q1 2019 Apr 18, 2019	BUY	$2.35 - $4.19 $35,677 - $63,612	15,182 Added 1608.26%	16,126 $0
Q4 2018 Jan 16, 2019	SELL	$2.17 - $3.8 $53,946 - $94,468	-24,860 Reduced 96.34%	944 $2,000
Q3 2018 Oct 23, 2018	BUY	$3.0 - $4.05 $38,010 - $51,313	12,670 Added 96.47%	25,804 $99,000
Q2 2018 Jul 30, 2018	SELL	$3.15 - $4.7 $63,255 - $94,380	-20,081 Reduced 60.46%	13,134 $43,000
Q1 2018 Apr 26, 2018	BUY	$2.5 - $4.45 $39,340 - $70,025	15,736 Added 90.03%	33,215 $147,000
Q4 2017 Jan 10, 2018	BUY	$2.35 - $4.0 $40,450 - $68,852	17,213 Added 6471.05%	17,479 $43,000
Q3 2017 Oct 25, 2017	BUY	$2.75 - $3.95 $731 - $1,050	266	266 $1,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.1M

Call Options Held

79.2K

Put Options Held

12.7K

Silverarc Capital Management, LLC

1.5M
Shares

$2.27 Million
0.68% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.29M
Shares

$1.94 Million
0.0% of portfolio
Taylor Frigon Capital Management LLC

1.2M
Shares

$1.81 Million
1.09% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

1.09M
Shares

$1.65 Million
0.02% of portfolio
Macquarie Group LTD Australia, C3

1.02M
Shares

$1.54 Million
0.0% of portfolio

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account